Obesity and diabetes in TNF-α receptor-deficient mice

Journal of Clinical Investigation

Volumn 102, Issue 2, 1998, Pages 402-411

  Schreyer, Sandra A ^a   Chua Jr , Streamson C ^b   Leboeuf, Renée C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cytokine; Diet; Hyperglycemia; Insulin resistance; Leptin

Indexed keywords

LEPTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE HOMEOSTASIS; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032528177     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2849     Document Type: Article

References (56)

1. Granner, D.K., and R.M. O'Brien. 1992. Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care. 15:369-396.
2. Elbein, S.C., M.D. Hoffman, K.L. Bragg, and R.A. Mayorga. 1994. The genetics of NIDDM. An update. Diabetes Care. 17:1523-1533.
3. Horton, E.S. 1995. NIDDM - the devastating disease. Diabetes Res. Clin. Prac. 28:S3-S11.
4. Hanis, C.L., E. Boerwinkle, R. Chakraborty, D.L. Ellsworth, P. Concannon, B. Stirling, V.A. Morrison, B. Wapelhorst, R.S. Spielman, K.J. Gogolin-Ewens, et al. 1996. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet. 13:161-166.
5. Stern, M.P., B.D. Mitchell, J. Blangero, L. Reinhart, C.M. Kammerer, C.R. Harrison, P.A. Shipman, P. O'Connell, M.L. Frazier, and J.W. MacCluer. 1996. Evidence for a major gene for type II diabetes and linkage analysis with selected candidate genes in Mexican-Americans. Diabetes. 45:563-568.
6. Hanson, R.L., R.C. Elston, D.J. Pettitt, P.H. Bennett, and W.C. Knowler. 1995. Segregation analysis of non-insulin-dependent diabetes mellitus in Pima Indians: evidence for a major gene effect. Am. J. Hum. Genetics. 57:160-170.
7. Comuzzie, A.G., J.E. Hixson, L. Almasy, B.D. Mitchell, M.C. Mahaney, T.D. Dyer, M.P. Stern, J.W. MacCluer, and J. Blangero. 1997. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat. Genet. 15:273-276.
8. Hotamisligil, G.S., N.S. Shargill, and B.M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:87-91.
9. Hotamisligil, G.S., A. Budavari, D. Murray, and B.M. Spiegelman. 1994. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J. Clin. In vest. 94:1543-1549.
10. Hotamisligil, G.S., D.L. Murray, L.N. Choy, and B.M. Spiegelman. 1994. Tumor necrosis factor-α inhibits signaling from the insulin receptor. Proc: Natl. Acad. Sci. USA. 91:4854-4858.
11. Hotamisligil, G.S., P. Arner, J.F. Caro, R.L. Atkinson, and B.M. Spiegelman. 1995. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415.
12. Saghizadeh, M., J.M. Ong, W.T. Garvey, R.R. Henry, and P.A. Kern. 1996. The expression of TNF-α by human muscle. Relationship to insulin resistance. J. Clin. Invest. 97:1111-1116.
13. Kern, P.A. 1997. Potential role of TNF-α and lipoprotein lipase as candidate genes for obesity. J. Nutr. 127:1917S-1922S.
14. Kern, P.A., M. Saghizadeh, J.M. Ong, R.J. Bosch, R. Deem, and R.B. Simsolo. 1995. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95:2111-2119.
15. Hofmann, C., K. Lorenz, S.S. Braithwaite, J.R. Colca, B.J. Palazuk, G.S. Hotamisligil, and B.M. Spiegelman. 1994. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 134:264-270.
16. Ofei, F., S. Hurel, J. Newkirk, M. Sopwith, and R. Taylor. 1996. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes. 45:881-885.
17. Begum, N., and L. Ragolia. 1996. Effect of tumor necrosis factor-α on insulin action in cultured rat skeletal muscle cells. Endocrinology. 137:2441-2446.
18. Lang, C.H., C. Dobrescu, and G.J. Bagby. 1992. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 130:43-52.
19. Dahn, M.S., C.J. Hsu, P.P. Lange, and L.S. Jefferson. 1994. Effects of tumor necrosis factor-α on glucose and albumin production in primary cultures of rat hepatocytes. Metabolism. 43:476-480.
20. Zhang, S., and K. Kim. 1995. TNF-α inhibits glucose-induced insulin secretion in a pancreatic β cell line (INS-1). FEBS Lett. 377:237-239.
21. Vara, E., J. Arias-Diaz, C. Garcia, and J.L. Balibrea. 1994. Effect of cytokines on insulin release and glucose oxidation by cultured human islets of ventral and dorsal origin. Transplant. Proc. 26:695-697.
22. Campbell, I.L., A. Iscaro, and L.C. Harrison. 1988. IFN-γ and tumor necrosis factor-α. Cytotoxicity to murine islets of Langerhans. J. Immunol. 141: 2325-2329.
23. Hotamisligil, G.S., and B.M. Spiegelman. 1994. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes. 43:1271-1278.
24. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino, Jr., and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88:9292-9296.
25. Pfeffer, K., T. Matsuyama, T.M. Kundig, J.A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P.S. Ohashi, M. Kronke, and T.W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73:457-467.
26. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor I are resistant Io TNF-mediated toxicity but highly susceptible to infection by Lysteria monocytogenes. Nature. 364:798-802.
27. Mackay, F., J. Rothe, H. Bluethmann, H. Loetscher, and W. Lesslauer. 1994. Differential responses of fibroblasts from wild-type and TNF-P55-deficient mice to mouse and human TNF-α activation. J. Immunol. 153:5274-5284.
28. Erickson, S.L., F.J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K.C. Sheehan, R.D. Schreiber, D.V. Goeddel, and M.W. Moore. 1994. Decreased sensitivity to tumor necrosis factor but normal T cell development in TNF receptor-2-deficient mice. Nature. 372:560-563.
29. LeBoeuf, R.C., and S.A. Schreyer. 1998. The role of tumor necrosis factor-α receptors in atherosclerosis. Trends Cardiovasc. Med. 8:131-138.
30. Morin, C.L., I.R. Schlaepfer, and R.H. Eckel. 1995. Tumor necrosis factor-α eliminates binding of NF-Y and an octamer binding protein to the lipoprotein lipase promoter in 3T3-L1 adipocytes. J. Clin. Invest. 95:1684-1689.
31. Peraldi, P., G.S. Hotamisligil, W.A. Buurman, M.F. White, and B.M. Speigelman. 1996. Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271:13018-13022.
32. Hotamisligil, G.S., P. Arner, R.L. Atkinson, and B.M. Spiegelman. 1997. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes. 46:451-155.
33. Ventre, J., T. Doebber, M. Wu, K. MacNaul, K. Stevens, M. Pasparakis, G. Kollias, and D.E. Moller. 1997. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes. 46:1526-1531.
34. Uysal, K.T., S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature. 389:610-614.
35. Surwit, R.S., C.M. Kuhn, C. Cochrane, J.A. McCubbin, and M.N. Feinglos. 1988. Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 37:1163-1167.
36. Surwit, R.S., M.F. Seldin, C.M. Kuhn, C. Cochrane, and M.N. Feinglos. 1991. Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes. 40:82-87.
37. Peschon, J.P., D.S. Torrance, K.L. Stocking, M.B. Glaccum, C. Otten, C.R. Willis, K. Charrier, P.J. Morrissey, C.B. Ware, and D.M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:943-952.
38. Chen, H., O. Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, S.J. Ellis, N.D. Lakey, J. Culpepper, K.J. Moore, R.E. Breitbart, G.M. Duyk, R.I. Tepper, and J.P. Morgenstern. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:491-495.
39. Lee, G.H., R. Proenca, J.M. Montez, K.M. Carroll, J.G. Darvishzadeh, J.I. Lee, J.M. Friedman. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632-635.
40. LeBoeuf, R.C., M. Caldwell, and E. Kirk. 1994. Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. J. Lipid Res. 35:121-133.
41. Jensen, D.R., I.R. Schlaepfer, C.L. Morin, D.S. Pennington, T. Marcell, S.M. Ammon, H.A. Gutierrez, and R.H. Eckel. 1997. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am. J. Physiol. 273:R683-689.
42. Hamann, A.J., S. Flier, and B.B. Lowell. 1996. Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes and hyperlipidemia. Endocrinology. 137:21-29.
43. Searle, T.W., J.D. Murray, and P.J. Baker. 1992. Effect of increased production of growth hormone on body composition in mice: transgenic versus control. J. Endocrinology. 132:285-291.
44. Susulic, V.S. R.C. Frederich, J. Lawitts, E. Tozzo, B.B. Kahn, M.E. Harper, J. Himms-Hagen, J.S. Flier, and B.B. Lowell. 1995. Targeted disruption of the β 3-adrenergic receptor gene. J. Biol. Chem. 270:29483-29492.
45. Erickson, J.C., G. Hollopeter, and R.D. Palmiter. 1996. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274: 1704-1707.
46. Havel, P.J., S. Kasim-Karakas, W. Mueller, P.R. Johnson, R.L. Gingerich, and J.S. Stern. 1996. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J. Clin. Endocrinol. Metab. 81:4406-4413.
47. Frederich, R.C., A. Hamann, S. Anderson, B. Lollmann, B.B. Lowell, and J.S. Flier. 1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1:1311-1314.
48. Lonnqvist, F., A. Wennlund, and P. Arner. 1997. Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int. J. Obes. Relat. Metab. Disord. 21:255-260.
49. Kirchgessner, T.G., K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil. 1997. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J. Clin. Invest. 100:2777-2782.
50. Saad, M.F., A. Khan, A. Sharma, R. Michael, M.G. Riad-Gabriel, R. Boyadjian, S.D. Jinagouda, G.M. Steil, and V. Kamdar. 1998. Physiological insulinemia acutely modulates plasma leptin. Diabetes. 47:544-549.
51. Muller, G., J. Ertl, M. Gerl, and G. Preibisch. 1997. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J. Biol. Chem. 272:10585-10593.
52. Cohen, B., D. Novick, and M. Rubinstein. 1996. Modulation of insulin activities by leptin. Science. 274:1185-1188.
53. Chen, N.G., A.G. Swick, and D.R. Romsos. 1997. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice. J. Clin. Invest. 100:1174-1179.
54. Emilsson, V., Y.-L. Liu, M.A. Cawthorne, N.M. Morton, and M. Davenport. 1997. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 46:313-316.
55. Vaisse, C., J.L. Halaas, C.M. Horvath, J.E. Darnell, Jr., M. Stoffel, and J.M. Friedman. 1996. Leptin activation of stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14:95-97.
56. Schwartz, M.W., D.G. Baskin, T.R. Bukowski, J.L. Kuijper, D. Foster, G. Lasser, D.E. Prunkard, D. Porte, Jr., S.C. Woods, R.J. Seeley, and D.S. Weigle. 1996. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:531-535.